Page last updated: 2024-08-25

clarithromycin and Coronary Artery Disease

clarithromycin has been researched along with Coronary Artery Disease in 10 studies

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (30.00)29.6817
2010's5 (50.00)24.3611
2020's2 (20.00)2.80

Authors

AuthorsStudies
Lee, TH; Liao, PC; Lin, CK; Lin, CL1
Ärnlöv, J; Gluud, C; Harutyunyan, M; Hilden, J; Jakobsen, JC; Jensen, GB; Johansen, JS; Kastrup, J; Kjøller, E; Larsson, A; Sajadieh, A; Schroder, J; Winkel, P1
Bjerre, M; Flyvbjerg, A; Gluud, C; Hansen, JF; Hilden, J; Jensen, GB; Kastrup, J; Kjøller, E; Kolmos, HJ; Skoog, M; Winkel, P1
Gluud, C; Hansen, JF; Hilden, J; Jensen, GB; Kastrup, J; Kjøller, E; Kolmos, HJ; Lindschou, J; Skoog, M; Winkel, P1
Li, C; Li, X; Liu, G; Wang, M; Wang, Z; Zhou, L1
Fischer Hansen, J; Gluud, C; Hildebrandt, P; Hilden, J; Jensen, GB; Jespersen, CM; Kastrup, J; Kjøller, E; Kolmos, HJ; Winkel, P1
Berg, HF; Kluytmans, JA; Maraha, B; Peeters, MF; Scheffer, GJ1
Muhlestein, JB1

Reviews

1 review(s) available for clarithromycin and Coronary Artery Disease

ArticleYear
Antibiotic treatment of atherosclerosis.
    Current opinion in lipidology, 2003, Volume: 14, Issue:6

    Topics: Animals; Anti-Bacterial Agents; Arteriosclerosis; Azithromycin; C-Reactive Protein; Cardiovascular Diseases; Chlamydophila Infections; Chlamydophila pneumoniae; Clarithromycin; Coronary Artery Disease; Coronary Restenosis; Diet, Atherogenic; Fluoroquinolones; Gatifloxacin; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Models, Animal; Myocardial Ischemia; Rabbits; Randomized Controlled Trials as Topic; Roxithromycin; Treatment Outcome

2003

Trials

3 trial(s) available for clarithromycin and Coronary Artery Disease

ArticleYear
Prognosis and Reclassification by YKL-40 in Stable Coronary Artery Disease.
    Journal of the American Heart Association, 2020, 03-03, Volume: 9, Issue:5

    Topics: Aged; Anti-Bacterial Agents; Biomarkers; C-Reactive Protein; Chitinase-3-Like Protein 1; Clarithromycin; Coronary Artery Disease; Female; Follow-Up Studies; Humans; Male; Middle Aged; Predictive Value of Tests; Prognosis; Proportional Hazards Models; Survival Rate

2020
Clarithromycin for stable coronary heart disease increases all-cause and cardiovascular mortality and cerebrovascular morbidity over 10years in the CLARICOR randomised, blinded clinical trial.
    International journal of cardiology, 2015, Mar-01, Volume: 182

    Topics: Aged; Anti-Bacterial Agents; Cause of Death; Clarithromycin; Coronary Artery Disease; Denmark; Female; Follow-Up Studies; Forecasting; Humans; Male; Morbidity; Retrospective Studies; Single-Blind Method; Stroke

2015
Effect of clarithromycin on inflammatory markers in patients with atherosclerosis.
    Clinical and diagnostic laboratory immunology, 2003, Volume: 10, Issue:4

    Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Biomarkers; C-Reactive Protein; Clarithromycin; Coronary Artery Bypass; Coronary Artery Disease; Double-Blind Method; Female; Humans; Inflammation; Interleukin-6; Interleukin-8; Male; Middle Aged; Prospective Studies; Receptors, Interleukin-2; Treatment Failure; Tumor Necrosis Factor-alpha

2003

Other Studies

6 other study(ies) available for clarithromycin and Coronary Artery Disease

ArticleYear
Cardiac events after using clarithromycin for anti-Helicobacter pylori therapy in patients with coronary artery disease.
    Medicine, 2023, Nov-10, Volume: 102, Issue:45

    Topics: Anti-Bacterial Agents; Clarithromycin; Coronary Artery Disease; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Retrospective Studies

2023
Clarithromycin in patients with coronary artery disease.
    The Medical letter on drugs and therapeutics, 2018, 05-21, Volume: 60, Issue:1547

    Topics: Anti-Bacterial Agents; Arrhythmias, Cardiac; Bacterial Infections; Clarithromycin; Coronary Artery Disease; Humans; Risk Factors

2018
Osteoprotegerin independently predicts mortality in patients with stable coronary artery disease: the CLARICOR trial.
    Scandinavian journal of clinical and laboratory investigation, 2014, Volume: 74, Issue:8

    Topics: Aged; Anti-Bacterial Agents; Clarithromycin; Coronary Artery Disease; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Multicenter Studies as Topic; Osteoprotegerin; Prognosis; Proportional Hazards Models; Randomized Controlled Trials as Topic; Risk Factors

2014
Macrolides use and the risk of sudden cardiac death.
    Expert review of anti-infective therapy, 2016, Volume: 14, Issue:6

    Topics: Anti-Bacterial Agents; Arrhythmias, Cardiac; Azithromycin; Clarithromycin; Coronary Artery Disease; Coronary Disease; Death, Sudden, Cardiac; Erythromycin; Humans; Macrolides; Plaque, Atherosclerotic; Risk Factors; Torsades de Pointes

2016
Excess sudden cardiac deaths after short-term clarithromycin administration in the CLARICOR trial: why is this so, and why are statins protective?
    Cardiology, 2011, Volume: 118, Issue:1

    Topics: Anti-Bacterial Agents; Clarithromycin; Coronary Artery Disease; Death, Sudden, Cardiac; Denmark; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Randomized Controlled Trials as Topic

2011
Antibiotics for heart health?
    Health news (Waltham, Mass.), 2002, Volume: 8, Issue:5

    Topics: Anti-Bacterial Agents; Bacterial Infections; Chest Pain; Clarithromycin; Coronary Artery Disease; Humans; Inflammation

2002